← board
MENS
distress 5/10 · elevated risk$2.640%today-96% from 52w high
Revenue
pre-revenue
Liquidity
$1M
Runway
0.4 yrs
Shares 1y
—
Price & events
-16.5% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+14.8%
1W
+61.0%
1M
+16.3%
3M
-12.9%
6M
-76.3%
1Y
—
2Y
—
5Y
-73.9%
All
Overview
- Market Cap
- $200.71M
- Enterprise Value
- $201.66M
- Volume
- 7.84K
- 52 Week Range
- $1.46 – $65.62
- Total Shares
- 76.03M
- Float Shares
- 26.94M
- Short %
- 0.51%
- % Held by Insiders
- 62.20%
- % Held by Institutions
- 0.71%
- RVOL
- 0.06x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.